Replies to post #189164 on Biotech Values

[Rocky3]

they certainly have the cash for it

They have the cash for about anything. At sub 30, I would suggest authorizing a sizable buy-back. I know that it is rare in bio-land and somewhat risky given the "cure" nature of its drugs, but where can it find a similar return?